US Broker Ratings

Elanco Animal Health (ELAN) Stock Analysis: Growth Potential and Market Position in the Animal Health Industry

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a formidable player in the healthcare sector, specifically within the specialized realm of drug manufacturing for both pets and farm animals. With..

Danaher Corporation (DHR) Stock Analysis: Unlocking a 22.62% Potential Upside Amid Robust Analyst Ratings

Danaher Corporation (NYSE: DHR), a giant in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors seeking growth and stability in an ever-evolving industry. With..

Exact Sciences Corporation (EXAS) Stock Analysis: A 17% Upside Potential in the Healthcare Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS), a prominent name in the healthcare diagnostics sector, has garnered significant attention from investors, particularly with its innovative cancer screening and diagnostic test products. With..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Examining a 24.68% Potential Upside in the Healthcare Sector

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands as a stalwart in the healthcare sector, particularly in the medical instruments and supplies industry. With a commanding market capitalization of $167.36 billion, Intuitive..

The Cooper Companies, Inc. (COO) Stock Analysis: Eyeing a 24% Upside in Healthcare Innovation

The Cooper Companies, Inc. (NYSE: COO) is a prominent name in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $13.54 billion, Cooper..

Qiagen N.V. (QGEN) Stock Analysis: Navigating a 10.18% Potential Upside in the Diagnostics Sector

Qiagen N.V. (QGEN), a prominent player in the healthcare sector, operates within the diagnostics and research industry. Headquartered in Venlo, the Netherlands, Qiagen specializes in transforming biological samples into molecular..

Corcept Therapeutics (CORT) Stock Analysis: Exploring a 93.92% Potential Upside in Biotechnology

Corcept Therapeutics Incorporated (NASDAQ: CORT) presents a compelling opportunity within the biotechnology sector, catering to the development of treatments for severe endocrinologic, oncologic, metabolic, and neurologic disorders. Headquartered in Redwood..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Diverse Portfolio with a 5.63% Upside Potential

Avantor, Inc. (NYSE: AVTR), a significant player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $9.07 billion, Avantor stands out for..

United Therapeutics Corporation (UTHR): Stock Analysis Reveals 11.87% Potential Upside for Investors

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a robust market capitalization of $18.11 billion, this biotechnology..

AstraZeneca PLC (AZN) Stock Analysis: Exploring Growth Potential and Analyst Ratings

AstraZeneca PLC (AZN), a titan in the healthcare sector, continues to capture investor attention with its expansive portfolio in the drug manufacturing industry. With a market capitalization of $253.94 billion,..

Quest Diagnostics (DGX) Stock Analysis: A Solid Healthcare Bet with Over 2% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX) stands as a formidable player in the healthcare sector, specifically in diagnostics and research. With a robust market capitalization of $20.52 billion, the company has..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 31.58% Upside Amidst Biotech Innovation

Roivant Sciences Ltd. (NASDAQ: ROIV) stands out in the biotechnology sector with a robust market capitalization of $8.82 billion. As an innovative leader in developing breakthrough medicines and technologies, the..

Veeva Systems Inc. (VEEV) Stock Analysis: Unpacking a 16% Potential Upside and Strong Buy Ratings

Veeva Systems Inc. (NYSE: VEEV), a prominent player in the health information services sector, continues to capture investor attention with its innovative cloud-based solutions tailored for the life sciences industry...

Fresenius Medical Care AG (FMS) Stock Analysis: Unveiling a 22.60% Upside Potential in Healthcare

Investors looking for opportunities in the healthcare sector should take a closer look at Fresenius Medical Care AG (FMS), a global leader in dialysis and renal healthcare services. With its..

Walgreens Boots Alliance, Inc. (WBA) Stock Analysis: Is an 8.35% Dividend Yield Worth the Risk?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a stalwart in the healthcare and pharmaceutical retail sector, presents an intriguing case for investors, particularly those with an appetite for high dividend yields...

Humana Inc. (HUM) Stock Analysis: Navigating Potential Amid Revenue Growth and Analyst Sentiment

Humana Inc. (NYSE: HUM), a prominent player in the healthcare plans industry, continues to be a focal point for investors seeking opportunities in the healthcare sector. With a market capitalization..

ICON plc (ICLR) Stock Analysis: A 26% Potential Upside Amidst Healthcare Innovation

Investors with an eye on the healthcare sector should take a closer look at ICON plc (NASDAQ: ICLR), a prominent player in the diagnostics and research industry. With its headquarters..

Summit Therapeutics Inc. (SMMT): Analyst Ratings and Potential Upside in Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT) stands as a notable player within the biotechnology industry, specifically focusing on the development of innovative therapies aimed at addressing unmet medical needs. Based in..

argenx SE (ARGX) Stock Analysis: Biotechnology Powerhouse with 8.28% Upside Potential

argenx SE (NASDAQ: ARGX), a Netherlands-based biotechnology firm, has garnered significant attention in the healthcare sector, particularly for its innovative therapies targeting autoimmune diseases. With a market capitalization of $45.95..

DaVita Inc. (DVA) Investor Outlook: Assessing a Potential 11% Upside Amid Strong Cash Flow

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specializes in providing kidney dialysis services across the United States. With a market capitalization of $9.86 billion, DaVita stands..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds